Form 8-K - Current report:
SEC Accession No. 0000950170-22-000398
Filing Date
2022-01-19
Accepted
2022-01-19 16:10:00
Documents
12
Period of Report
2022-01-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tern-20220119.htm   iXBRL 8-K 45882
  Complete submission text file 0000950170-22-000398.txt   169504

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20220119_lab.xml EX-101.LAB 14668
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20220119_pre.xml EX-101.PRE 10787
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20220119.xsd EX-101.SCH 2504
6 EXTRACTED XBRL INSTANCE DOCUMENT tern-20220119_htm.xml XML 5121
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 22538840
SIC: 2834 Pharmaceutical Preparations